CRANEWARE PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,220 GBX | -0.89% |
|
+3.26% | +26.86% |
| Apr. 16 | Craneware extends share buyback scheme again by three months | AN |
| Apr. 16 | Craneware plc's Equity Buyback Plan Extended till July 17, 2024. | CI |
Financials (USD)
| Sales 2024 * | 185M | Sales 2025 * | 198M | Capitalization | 976M |
|---|---|---|---|---|---|
| Net income 2024 * | 11M | Net income 2025 * | 15M | EV / Sales 2024 * | 5.27 x |
| Net cash position 2024 * | 3.03M | Net cash position 2025 * | 12.6M | EV / Sales 2025 * | 4.86 x |
| P/E ratio 2024 * |
103
x | P/E ratio 2025 * |
76.9
x | Employees | 734 |
| Yield 2024 * |
1.3% | Yield 2025 * |
1.38% | Free-Float | 79.16% |
More Fundamentals
* Assessed data
More news
More news
| 1 day | -0.13% | ||
| 1 week | +4.05% | ||
| Current month | +1.68% | ||
| 1 month | +1.22% | ||
| 3 months | +13.55% | ||
| 6 months | +44.32% | ||
| Current year | +27.83% |
1 week
2 156.00
2 250.00
1 month
2 130.002 250.00
Current year
1 700.002 270.00
1 year
1 060.002 270.00
3 years
1 060.002 830.00
5 years
1 060.003 248.00
10 years
473.003 650.00
| Managers | Title | Age | Since |
|---|---|---|---|
Keith Neilson
FOU | Founder | 55 | 99-04-30 |
Craig Preston
DFI | Director of Finance/CFO | 53 | 08-09-14 |
Abhilesh Gandhi
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Russ Rudish
BRD | Director/Board Member | 72 | 14-08-27 |
Keith Neilson
FOU | Founder | 55 | 99-04-30 |
Colleen M. Blye
BRD | Director/Board Member | 64 | 13-11-11 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | -.--% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 2,220 | -0.89% | 16 702 |
| 24-04-18 | 2,240 | +0.90% | 37,962 |
| 24-04-17 | 2,220 | +1.83% | 113,856 |
| 24-04-16 | 2,180 | -0.91% | 147,001 |
| 24-04-15 | 2,200 | +2.33% | 486,692 |
Delayed Quote London S.E., April 19, 2024 at 07:34 am EDT
More quotes
Craneware plc is a United Kingdom company that is engaged in the development, licensing, and ongoing support of computer software for the United States healthcare industry. Its value cycle insights are delivered through its Trisus platform for revenue integrity and 340B management, as well as margin and operational intelligence. Its applications and team of experts contextualize operational, financial, and clinical data, providing insights that clearly demonstrate realistic revenue integrity and 340B compliance opportunities for its customers. Its solutions include Trisus Pricing Transparency, Trisus Pricing Analyzer, Trisus Chargemaster, Insight Medical Necessity, Trisus Claims Informatics, Trisus Supply, Appeals Services, Trisus Healthcare Intelligence, Trisus Supplies Assistant, Trisus Medication Analytic Solutions, Sentinel, Sentrex, Sentrex 330, Referral Verification System (Sentrex), Referral Verification System (Senturion), Sentry Core, Senturion Professional Service and others.
Sector
Software
Calendar
2024-06-23
- HFMA Conference
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
27.92
USD
Average target price
33.79
USD
Spread / Average Target
+21.03%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +27.83% | 976M | |
| +7.52% | 3,004B | |
| +0.93% | 79.28B | |
| +4.97% | 77.94B | |
| -13.71% | 53.9B | |
| -18.60% | 50.22B | |
| +23.06% | 46.76B | |
| +12.30% | 39.49B | |
| +39.01% | 31.91B | |
| -12.62% | 23.99B |
- Stock Market
- Equities
- CRW Stock
